CAS 152563-30-9 | BIDI-003 : Bidisomide
(World's Largest Pharmaceutical Supplier)
- CAS Number: 152563-30-9
- Stock: 999g
- Assay: 0.00%
CAS 152563-30-9 is a chemical compound with the molecular formula C20H25N5O2S and the systematic name (2R)-N-[(1S)-1-(2,3-dihydro-1-benzofuran-4-yl)ethyl]-2-(4-methyl-1,3-thiazol-5-yl)pyrrolidine-1,2-dicarboxamide. It is also known by its trade name Maraviroc.
Chemical Properties
CAS 152563-30-9 is a white to off-white crystalline powder with a molecular weight of 419.52 g/mol. It is soluble in water, methanol, and ethanol, and insoluble in chloroform, ether, and hexane. It has a melting point of 214-216°C.
Applications
CAS 152563-30-9 is a medication used to treat HIV-1 infection. It is a type of antiretroviral medication that works by blocking the entry of the virus into human cells. It is used in combination with other antiretroviral drugs and is only effective against HIV-1, not HIV-2.
Maraviroc was approved by the US Food and Drug Administration (FDA) in 2007 and is marketed by ViiV Healthcare. It is available in tablet form and is taken orally twice daily.
Side Effects
The use of CAS 152563-30-9 may cause some side effects, including cough, fever, rash, and fatigue. More serious side effects may include liver problems, allergic reactions, and an increased risk of infections.
Conclusion
CAS 152563-30-9 is an important medication used in the treatment of HIV-1 infection. It is effective in blocking the entry of the virus into human cells and is used in combination with other antiretroviral drugs. While it may cause some side effects, the benefits of its use in treating HIV-1 infection outweigh the risks.